393 related articles for article (PubMed ID: 19465707)
1. Strategies for managing coinfection with hepatitis B virus and HIV.
Sherman M
Cleve Clin J Med; 2009 May; 76 Suppl 3():S30-3. PubMed ID: 19465707
[TBL] [Abstract][Full Text] [Related]
2. Special considerations and treatment of patients with HBV-HIV coinfection.
Dieterich DT
Antivir Ther; 2007; 12 Suppl 3():H43-51. PubMed ID: 18284182
[TBL] [Abstract][Full Text] [Related]
3. European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults.
Rockstroh JK; Bhagani S; Benhamou Y; Bruno R; Mauss S; Peters L; Puoti M; Soriano V; Tural C;
HIV Med; 2008 Feb; 9(2):82-8. PubMed ID: 18257771
[TBL] [Abstract][Full Text] [Related]
4. Reversibility of cirrhosis in HIV/HBV coinfection.
Mallet VO; Dhalluin-Venier V; Verkarre V; Correas JM; Chaix ML; Viard JP; Pol S
Antivir Ther; 2007; 12(2):279-83. PubMed ID: 17503671
[TBL] [Abstract][Full Text] [Related]
5. Impact of highly active antiretroviral therapy (HAART) on the natural history of hepatitis B virus (HBV) and HIV coinfection: relationship between prolonged efficacy of HAART and HBV surface and early antigen seroconversion.
Miailhes P; Trabaud MA; Pradat P; Lebouché B; Chevallier M; Chevallier P; Zoulim F; Trepo C
Clin Infect Dis; 2007 Sep; 45(5):624-32. PubMed ID: 17682999
[TBL] [Abstract][Full Text] [Related]
6. Impact and management of hepatitis B and hepatitis C virus co-infection in HIV patients.
Kumar R; Singla V; Kacharya Sk
Trop Gastroenterol; 2008; 29(3):136-47. PubMed ID: 19115605
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of entecavir for chronic HBV in HIV/HBV coinfected patients receiving lamivudine as part of antiretroviral therapy.
Pessôa MG; Gazzard B; Huang AK; Brandão-Mello CE; Cassetti I; Mendes-Corrêa MC; Soriano V; Phiri P; Hall A; Brett-Smith H
AIDS; 2008 Sep; 22(14):1779-87. PubMed ID: 18753861
[TBL] [Abstract][Full Text] [Related]
8. Impact of hepatitis D virus infection on the long-term outcomes of patients with hepatitis B virus and HIV coinfection in the era of highly active antiretroviral therapy: a matched cohort study.
Sheng WH; Hung CC; Kao JH; Chang SY; Chen MY; Hsieh SM; Chen PJ; Chang SC
Clin Infect Dis; 2007 Apr; 44(7):988-95. PubMed ID: 17342655
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B and C viral load changes following initiation of highly active antiretroviral therapy (HAART) in patients with advanced HIV infection.
Asmuth DM; Busch MP; Laycock ME; Mohr BA; Kalish LA; van der Horst CM;
Antiviral Res; 2004 Aug; 63(2):123-31. PubMed ID: 15302141
[TBL] [Abstract][Full Text] [Related]
10. Does treatment of hepatitis B virus (HBV) infection reduce hepatitis delta virus (HDV) replication in HIV-HBV-HDV-coinfected patients?
Sheldon J; Ramos B; Toro C; Ríos P; Martínez-Alarcón J; Bottecchia M; Romero M; Garcia-Samaniego J; Soriano V
Antivir Ther; 2008; 13(1):97-102. PubMed ID: 18389903
[TBL] [Abstract][Full Text] [Related]
11. Impact of hepatitis B virus co-infection on response to highly active antiretroviral treatment and outcome in HIV-infected individuals: a nationwide cohort study.
Omland LH; Weis N; Skinhøj P; Laursen A; Christensen PB; Nielsen HI; Møller A; Engsig F; Sørensen HT; Obel N
HIV Med; 2008 May; 9(5):300-6. PubMed ID: 18400077
[TBL] [Abstract][Full Text] [Related]
12. Identification of a novel hepatitis B virus precore/core deletion mutant in HIV/hepatitis B virus co-infected individuals.
Revill PA; Littlejohn M; Ayres A; Yuen L; Colledge D; Bartholomeusz A; Sasaduesz J; Lewin SR; Dore GJ; Matthews GV; Thio CL; Locarnini SA
AIDS; 2007 Aug; 21(13):1701-10. PubMed ID: 17690567
[TBL] [Abstract][Full Text] [Related]
13. Long-term follow-up of liver transplanted HIV/hepatitis B virus coinfected patients: perfect control of hepatitis B virus replication and absence of mitochondrial toxicity.
Tateo M; Roque-Afonso AM; Antonini TM; Medja F; Lombes A; Jardel C; Teicher E; Sebagh M; Roche B; Castaing D; Samuel D; Duclos-Vallee JC
AIDS; 2009 Jun; 23(9):1069-76. PubMed ID: 19417577
[TBL] [Abstract][Full Text] [Related]
14. Major causes of antiviral drug resistance and implications for treatment of hepatitis B virus monoinfection and coinfection with HIV.
Locarnini S; Warner N
Antivir Ther; 2007; 12 Suppl 3():H15-23. PubMed ID: 18284179
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic interventions for HIV infection and chronic viral hepatitis.
Cooper CL
Clin Infect Dis; 2005 Jul; 41 Suppl 1():S69-72. PubMed ID: 16265617
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B virus and HIV infection.
Martín-Carbonero L; Poveda E
Semin Liver Dis; 2012 May; 32(2):114-9. PubMed ID: 22760650
[TBL] [Abstract][Full Text] [Related]
17. Treatment of chronic hepatitis B in HIV co-infected patients.
Guan R
Med J Malaysia; 2005 Jul; 60 Suppl B():52-6. PubMed ID: 16108174
[TBL] [Abstract][Full Text] [Related]
18. New paradigms for treating hepatitis B in HIV/hepatitis B virus co-infected patients.
Martin-Carbonero L; Soriano V
J Antimicrob Chemother; 2010 Mar; 65(3):379-82. PubMed ID: 20085999
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of conditions associated with human immunodeficiency and hepatitis virus infections among persons with haemophilia, 2001-2003.
Goedert JJ;
Haemophilia; 2005 Sep; 11(5):516-28. PubMed ID: 16128897
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B and human immunodeficiency virus coinfection.
Thio CL
Hepatology; 2009 May; 49(5 Suppl):S138-45. PubMed ID: 19399813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]